The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
PharmaLedger – Building a Digital Trust Ecosystem in Healthcare |
The PharmaLedger Association (PLA) is a not-for-profit association based in Switzerland with the purpose to enable and foster a Digital Trust Ecosystem (DTE) in healthcare through a standardized and trusted open-source platform. PLA was formed fin 2022 to continue the work of the PharmaLedger project, a 3-year project funded by the European Commission and the pharmaceutical industry aimed at proving the value of blockchain solutions. Further information is available at https://pharmaledger.org/. The immediate (2023) goal is to launch a blockchain-enabled product, the electronic Product Information (ePI) solution, otherwise known as eLeaflet or ePIL. This would enable patients to freely access the latest approved version of a Product Information through a common industry app. It would also serve as a platform for additional supply chain use cases such as Detecting Falsified Medicines and Finished Goods Traceability. The Association also intends to pursue use cases in the Clinical domain such as Clinical Trial Recruitment and electronic Informed Consent.
Speaker(s):
Daniel
Fritz,
Domain Architect Supply Chain & ESO - PharmaLedger Industry Project Lead,
Novartis
Cuomo
MARCO,
Director Tech Products & Innovation,
Novartis Pharma AG
You must be logged in and own this session in order to
post comments.